Active vitamin D analogues and oral phosphate for the treatment of X-linked hypophosphataemia in paediatric patients: A systematic literature review and survey of expert opinion on current needs

2019 ◽  
Author(s):  
Gema Ariceta ◽  
Carmen de Lucas Collantes ◽  
Ravi Jandhyala ◽  
Zulf Mughal
Keyword(s):  
Vitamin D ◽  
Literature Review ◽  
Expert Opinion ◽  
Systematic Literature Review ◽  
Active Vitamin ◽  
Active Vitamin D ◽  
Vitamin D Analogues ◽  
Paediatric Patients

Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells

2007 ◽  
Vol 66 (3) ◽  
pp. 399-404 ◽  
Author(s):  
Ulrika Segersten ◽  
Peyman Björklund ◽  
Per Hellman ◽  
Göran Åkerström ◽  
Gunnar Westin
Keyword(s):  
Vitamin D ◽  
Active Vitamin ◽  
Active Vitamin D ◽  
Vitamin D Analogues

scholarly journals Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2–5 and on dialysis

2017 ◽  
Vol 32 (7) ◽  
pp. 1114-1127 ◽  
Author(s):  
Rukshana Shroff ◽  
Mandy Wan ◽  
Evi V. Nagler ◽  
Sevcan Bakkaloğlu ◽  
Mario Cozzolino ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Vitamin D ◽  
Clinical Practice ◽  
Kidney Disease ◽  
Active Vitamin ◽  
Practice Recommendations ◽  
Active Vitamin D ◽  
Vitamin D Analogues ◽  
Disease Stages

scholarly journals Renal complications in patients with chronic hypoparathyroidism on conventional therapy: a systematic literature review

2021 ◽  
Author(s):  
Elvira O. Gosmanova ◽  
Pascal Houillier ◽  
Lars Rejnmark ◽  
Claudio Marelli ◽  
John P. Bilezikian
Keyword(s):  
Vitamin D ◽  
Literature Review ◽  
Systematic Literature Review ◽  
Conventional Therapy ◽  
Pediatric Patients ◽  
Active Vitamin ◽  
Oral Calcium ◽  
Renal Complications ◽  
Increased Risk ◽  
Chronic Hypoparathyroidism

AbstractA systematic literature review was performed to summarize the frequency and nature of renal complications in patients with chronic hypoparathyroidism managed with conventional therapy. Methodology was consistent with the recommendations outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Peer-reviewed journal articles with specified medical subject heading terms were identified using the PubMed, EMBASE, and Cochrane databases. Data were extracted from eligible articles based on prespecified parameters for clinical outcomes of renal calcifications and disease. Because of the heterogeneity of the data, a meta-analysis could not be conducted. From 1200 potentially relevant articles, data were extracted from 13 manuscripts that reported data for ≥1 of the 19 predefined renal outcomes for ≥10 adult patients (n = 11 manuscripts) or pediatric patients (n = 2 manuscripts). The collective data provide evidence that adult and pediatric patients with chronic hypoparathyroidism and treated with conventional therapy (oral calcium and active vitamin D) had an increased risk of renal complications. The reported rate of nephrolithiasis was up to 36%, with the lowest rates in studies reporting shorter duration of disease. The rate of nephrocalcinosis was up to 38%. Some studies reported a combined nephrolithiasis/nephrocalcinosis outcome of 19% to 31%. Data for renal disease that encompassed a range of renal insufficiency to chronic kidney disease were reported in 10 articles; the reported rates ranged from 2.5% to 41%. In patients who receive long-term treatment with oral calcium and active vitamin D, chronic hypoparathyroidism may be associated with an increased risk of renal complications compared with the general population.

scholarly journals Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics

2022 ◽  
Vol 12 (1) ◽  
Author(s):  
Tomoya Soma ◽  
Ryotaro Iwasaki ◽  
Yuiko Sato ◽  
Tami Kobayashi ◽  
Eri Ito ◽  
...  
Keyword(s):  
Vitamin D ◽  
Tooth Extraction ◽  
Dental Treatment ◽  
Osteonecrosis Of The Jaw ◽  
Active Vitamin ◽  
Active Vitamin D ◽  
Vitamin D Analogues ◽  
Extraction Site ◽  
Treatment Administration ◽  
Anti Inflammatory

AbstractInvasive dental treatment such as tooth extraction following treatment with strong anti-bone resorptive agents, including bisphosphonates and denosumab, reportedly promotes osteonecrosis of the jaw (ONJ) at the extraction site, but strategies to prevent ONJ remain unclear. Here we show that in mice, administration of either active vitamin D analogues, antibiotics or anti-inflammatory agents can prevent ONJ development induced by tooth extraction during treatment with the bisphosphonate zoledronate. Specifically, tooth extraction during treatment with zoledronate induced osteonecrosis in mice, but administration of either 1,25(OH)2D3 or ED71, both active vitamin D analogues, significantly antagonized osteonecrosis development, even under continuous zoledronate treatment. 1,25(OH)2D3 or ED71 administration also significantly inhibited osteocyte apoptosis induced by tooth extraction and bisphosphonate treatment. Administration of either active vitamin D analogue significantly inhibited elevation of serum inflammatory cytokine levels in mice in response to injection of lipopolysaccharide, an infection mimetic. Furthermore, administration of either anti-inflammatory or antibiotic reagents significantly blocked ONJ development following tooth extraction and zoledronate treatment. These findings suggest that administration of active vitamin D, anti-inflammatory agents or antibiotics could prevent ONJ development induced by tooth extraction in patients treated with zoledronate.

Sign in / Sign up

Export Citation Format

Share Document